Assoz. Prof. Dr. Florian Kopp
T: +43-1-4277-55581
Winter term 2024
322010 VO Metabolismus und Wechselwirkungen - M9
322017 VO Klinische Pharmazie - M11
322020 PR PR Klinische Pharmazie und chemische Diagnostik - M11 - (6 Kurse)
960038 VU Digital Health - Tools und Datenbanken
960043 VO VO Grundlagen der Pharmakogenetik
Summer term 2024
322010 VO Metabolismus und Wechselwirkungen - M9
322017 VO Klinische Pharmazie - M11
322020 PR PR Klinische Pharmazie und chemische Diagnostik - M11 - (6 Kurse)
960023 VU Digital Health - Tools und Datenbanken
Winter term 2023
322010 VO Metabolismus und Wechselwirkungen - M9
322017 VO Klinische Pharmazie - M11
322020 PR PR Klinische Pharmazie und chemische Diagnostik - M11 - (6 Kurse)
950071 VU VU Digital Health Tools und Datenbanken
950210 VO VO Einführung in die Klinische Pharmazie
960023 VU Digital Health - Tools und Datenbanken
1 - 13 out of 13
1
Sanchez Juarez VM, Baumann A, Kromm F, Yergaliyev T, Brandt A, Scholda J et al. Oral supplementation of choline attenuates the development of alcohol-related liver disease (ALD). Molecular Medicine. 2024 Oct 18;30(1):181. doi: 10.1186/s10020-024-00950-4
Tenjović B, Bekić S, Ćelić A, Petri E, Scholda J, Kopp F et al. Synthesis and biological evaluation of novel D-ring fused steroidal N(2)-substituted-1,2,3-triazoles. RSC Medicinal Chemistry. 2024 Oct 18. doi: 10.1039/d4md00297k
Burger K, Jung F, Staltner R, Csarmann K, Schweiger K, Brandt A et al. A weekly 4-methylpyrazole treatment attenuates the development of non-obese metabolic dysfunction-associated steatotic liver disease (MASLD) in male mice: Role of JNK. European Journal of Clinical Investigation. 2024 Sept 29. doi: 10.1111/eci.14320
Janković ÐD, Šestić TL, Bekić SS, Savić MP, Ćelić AS, Scholda J et al. Development of new steroid-based hydrazide and (thio)semicarbazone compounds with anticancer properties. Journal of Steroid Biochemistry and Molecular Biology. 2024 Sept;242:106545. Epub 2024 May 16. doi: 10.1016/j.jsbmb.2024.106545
Scholda J, Nguyen TTA, Kopp F. Long noncoding RNAs as versatile molecular regulators of cellular stress response and homeostasis. Human Genetics. 2024 Jul;143(7):813-829. doi: 10.1007/s00439-023-02604-7
Brandt A, Kopp F. Long Noncoding RNAs in Diet-Induced Metabolic Diseases. International Journal of Molecular Sciences. 2024 May 23;25(11):5678. doi: 10.3390/ijms25115678
Decker S, Taschauer A, Geppl E, Pirhofer V, Schauer M, Pöschl S et al. Structure-based peptide ligand design for improved epidermal growth factor receptor targeted gene delivery. European Journal of Pharmaceutics and Biopharmaceutics. 2022 Jul;176:211-221. doi: 10.1016/j.ejpb.2022.05.004
Kopp F. Molecular functions and biological roles of long non‐coding RNAs in human physiology and disease. Journal of Gene Medicine. 2019 Aug;21(8):e3104. doi: 10.1002/jgm.3104
Kopp F. PUMILIO, but not RBMX, binding is required for regulation of genomic stability by noncoding RNA NORAD. eLife. 2019 Jul 25;8:e48625. doi: 10.7554/eLife.48625
Kopp F. PUMILIO hyperactivity drives premature aging of Norad-deficient mice. eLife. 2019 Feb 8;8:e42650. doi: 10.7554/eLife.42650
Kopp F. Functional Classification and Experimental Dissection of Long Noncoding RNAs. Cell. 2018 Jan;172(3):393-407. doi: 10.1016/j.cell.2018.01.011
Kopp F. An Argonaute phosphorylation cycle promotes microRNA-mediated silencing. Nature. 2017 Feb;542(7640):197-202. doi: 10.1038/nature21025
Kopp F. Noncoding RNA NORAD Regulates Genomic Stability by Sequestering PUMILIO Proteins. Cell. 2016 Jan;164(1-2):69-80. doi: 10.1016/j.cell.2015.12.017
1 - 13 out of 13
1
Rolle der nichtkodierenden RNA NORAD in Geweberegeneration
8/10/21 → 7/10/25
Project: Research funding
Department of Pharmaceutical Sciences
Josef-Holaubek-Platz 2 (UZA II)
1090 Wien
Room: 2E449A
T: +43-1-4277-55581